TSC2-deficient LAM patient-derived cells secreted ∼75% higher levels of PGE2 compared with TSC2-addback cells (p<0.01, Figure 3B), indicative of active AdPLA2. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.